{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:26:34Z","timestamp":1777670794275,"version":"3.51.4"},"reference-count":60,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder leading to deterioration of kidney function and end stage kidney disease (ESKD). A number of molecular processes are dysregulated in ADPKD but the exact mechanism of disease progression is not fully understood. We measured protein biomarkers being linked to ADPKD-associated molecular processes via ELISA in urine and serum in a cohort of ADPKD patients as well as age, gender and eGFR matched CKD patients and healthy controls. ANOVA and t-tests were used to determine differences between cohorts. Spearman correlation coefficient analysis was performed to assess coregulation patterns of individual biomarkers and renal function. Urinary epidermal growth factor (EGF) and serum apelin (APLN) levels were significantly downregulated in ADPKD patients. Serum vascular endothelial growth factor alpha (VEGFA) and urinary angiotensinogen (AGT) were significantly upregulated in ADPKD patients as compared with healthy controls. Arginine vasopressin (AVP) was significantly upregulated in ADPKD patients as compared with CKD patients. Serum VEGFA and VIM concentrations were positively correlated and urinary EGF levels were negatively correlated with urinary AGT levels. Urinary EGF and AGT levels were furthermore significantly associated with estimated glomerular filtration rate (eGFR) in ADPKD patients. In summary, altered protein concentrations in body fluids of ADPKD patients were found for the mechanistic markers EGF, APLN, VEGFA, AGT, AVP, and VIM. In particular, the connection between EGF and AGT during progression of ADPKD warrants further investigation.<\/jats:p>","DOI":"10.3390\/ijms22136885","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T22:24:57Z","timestamp":1624832697000},"page":"6885","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-9827","authenticated-orcid":false,"given":"Johannes","family":"Leierer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2087-5691","authenticated-orcid":false,"given":"Paul","family":"Perco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Hofer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1592-8202","authenticated-orcid":false,"given":"Susanne","family":"Eder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Dzien","sequence":"additional","affiliation":[{"name":"Medical Center Hentschelhof, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6896-2279","authenticated-orcid":false,"given":"Julia","family":"Kerschbaum","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rudnicki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Mayer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/wsbm.1289","article-title":"Systems Biology of Polycystic Kidney Disease: A Critical Review","volume":"7","author":"Menezes","year":"2015","journal-title":"WIREs Syst. Biol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.ackd.2009.12.001","article-title":"Diagnosis and Screening of Autosomal Dominant Polycystic Kidney Disease","volume":"17","author":"Pei","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2215\/CJN.03960318","article-title":"Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease","volume":"13","author":"Chebib","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","article-title":"Somatic PKD2 Mutations in Individual Kidney and Liver Cysts Support a \u201cTwo-Hit\u201d Model of Cystogenesis in Type 2 Autosomal Dominant Polycystic Kidney Disease","volume":"10","author":"Pei","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)65428-4","article-title":"Coordinate Expression of the Autosomal Dominant Polycystic Kidney Disease Proteins, Polycystin-2 And Polycystin-1, in Normal and Cystic Tissue","volume":"154","author":"Ong","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/ndt\/gfv422","article-title":"Albuminuria and Tolvaptan in Autosomal-Dominant Polycystic Kidney Disease: Results of the TEMPO 3:4 Trial","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.Org: Online Mendelian Inheritance in Man (OMIM\u00ae), an Online Catalog of Human Genes and Genetic Disorders","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: Shedding New Light on Drug Metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"F806","DOI":"10.1152\/ajprenal.00653.2016","article-title":"Meta-Analysis of Polycystic Kidney Disease Expression Profiles Defines Strong Involvement of Injury Repair Processes","volume":"312","author":"Malas","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_12","first-page":"073","article-title":"Using Information Content for Expanding Human Protein Coding Gene Interaction Networks","volume":"6","author":"Fechete","year":"2013","journal-title":"J. Comput. Sci. Syst. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The MTOR Pathway Is Regulated by Polycystin-1, and Its Inhibition Reverses Renal Cystogenesis in Polycystic Kidney Disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","article-title":"PKD1 Induces P21waf1 and Regulation of the Cell Cycle via Direct Activation of the JAK-STAT Signaling Pathway in a Process Requiring PKD2","volume":"109","author":"Bhunia","year":"2002","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Park, J.H., and Ahn, C. (2016). Genetic mechanisms of ADPKD. Cystogenesis, Springer. Advances in Experimental Medicine and Biology.","DOI":"10.1007\/978-981-10-2041-4"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A Human Gene That Shows Identity with the Gene Encoding the Angiotensin Receptor Is Located on Chromosome 11","volume":"136","author":"Heiber","year":"1993","journal-title":"Gene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1002\/jcp.26144","article-title":"Apelin\/APJ System: A Novel Potential Therapy Target for Kidney Disease","volume":"233","author":"Huang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhang, B., Wang, W., Wang, H., Yin, J., and Zeng, X. (2013). Promoting Effects of the Adipokine, Apelin, on Diabetic Nephropathy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060457"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/jcmm.12619","article-title":"Apelin Promotes Diabetic Nephropathy by Inducing Podocyte Dysfunction via Inhibiting Proteasome Activities","volume":"19","author":"Guo","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e3006","DOI":"10.1038\/cddis.2017.414","article-title":"Apelin Involved in Progression of Diabetic Nephropathy by Inhibiting Autophagy in Podocytes","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_22","first-page":"517","article-title":"Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-\u03921 in Autosomal Dominant Polycystic Kidney Disease Patients","volume":"20","author":"Kocer","year":"2016","journal-title":"Ther. Apher. Dial. Off. Peer-Rev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2013.08.007","article-title":"Apelin and Copeptin: Two Opposite Biomarkers Associated with Kidney Function Decline and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease","volume":"49","author":"Lacquaniti","year":"2013","journal-title":"Peptides"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/HYPERTENSIONAHA.108.113860","article-title":"Epidermal Growth Factor Receptor Signaling in the Kidney","volume":"52","author":"Melenhorst","year":"2008","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of Disease: Autosomal Dominant and Recessive Polycystic Kidney Diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Park, H.C., Kang, A.-Y., Jang, J.Y., Kim, H., Han, M., Oh, K.-H., Kim, S.H., Noh, J.W., Cheong, H.I., and Hwang, Y.-H. (2015). Increased Urinary Angiotensinogen\/Creatinine (AGT\/Cr) Ratio May Be Associated with Reduced Renal Function in Autosomal Dominant Polycystic Kidney Disease Patients. BMC Nephrol., 16.","DOI":"10.1186\/s12882-015-0075-8"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2215\/CJN.09941014","article-title":"Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan","volume":"10","author":"Harskamp","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.csbj.2019.06.019","article-title":"Computational Drug Screening Identifies Compounds Targeting Renal Age-Associated Molecular Profiles","volume":"17","author":"Koppelstaetter","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/labinvest.2008.158","article-title":"Hypoxia Response and VEGF-A Expression in Human Proximal Tubular Epithelial Cells in Stable and Progressive Renal Disease","volume":"89","author":"Rudnicki","year":"2009","journal-title":"Lab. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"316ra193","DOI":"10.1126\/scitranslmed.aac7071","article-title":"Tissue Transcriptome-Driven Identification of Epidermal Growth Factor as a Chronic Kidney Disease Biomarker","volume":"7","author":"Ju","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jash.2008.04.008","article-title":"Urinary Angiotensinogen as a Potential Biomarker of Severity of Chronic Kidney Diseases","volume":"2","author":"Kobori","year":"2008","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","article-title":"The Intrarenal Renin-Angiotensin System in Autosomal Dominant Polycystic Kidney Disease","volume":"287","author":"Soto","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000448296","article-title":"Renin-Angiotensin-Aldosterone System Antagonism and Polycystic Kidney Disease Progression","volume":"134","author":"Hian","year":"2016","journal-title":"Nephron"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000354317","article-title":"A Link between the Intrarenal Renin Angiotensin System and Hypertension in Autosomal Dominant Polycystic Kidney Disease","volume":"38","author":"Kocyigit","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/ki.2013.515","article-title":"Urinary Angiotensinogen Can Be Useful for Screening Patients with Polycystic Kidney Disease","volume":"85","author":"Kocyigit","year":"2014","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.bbadis.2010.10.004","article-title":"Epidermal Growth Factor-Mediated Proliferation and Sodium Transport in Normal and PKD Epithelial Cells","volume":"1812","author":"Zheleznova","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1523-1755.2001.060003847.x","article-title":"Influence of the Renin-Angiotensin System on Epidermal Growth Factor Expression in Normal and Cyclosporine-Treated Rat Kidney","volume":"60","author":"Yang","year":"2001","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2014.01.011","article-title":"Epidermal Growth Factor, from Gene Organization to Bedside","volume":"28","author":"Zeng","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.ajkd.2012.08.038","article-title":"Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP Relationship of Copeptin, a Surrogate Marker for Arginine Vasopressin, with Change in Total Kidney Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results from the CRISP Cohort","volume":"61","author":"Boertien","year":"2013","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","article-title":"Angiogenesis in Autosomal-Dominant Polycystic Kidney Disease","volume":"60","author":"Holubec","year":"2001","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.kint.2018.06.008","article-title":"HIF-1\u03b1 Promotes Cyst Progression in a Mouse Model of Autosomal Dominant Polycystic Kidney Disease","volume":"94","author":"Kraus","year":"2018","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/med.21477","article-title":"Hypoxia-Inducible Factor-1 (HIF-1) Inhibitors from the Last Decade (2007 to 2016): A \u201cStructure\u2013Activity Relationship\u201d Perspective","volume":"38","author":"Bhattarai","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.03.010","article-title":"Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in the Treatment of Renal Cell Carcinomas","volume":"120","author":"Roskoski","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3349\/ymj.2009.50.1.105","article-title":"TGF-\u03b2 Mediated Epithelial-Mesenchymal Transition in Autosomal Dominant Polycystic Kidney Disease","volume":"50","author":"Chea","year":"2009","journal-title":"Yonsei Med. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"29417","DOI":"10.1038\/srep29417","article-title":"Identification of Cyclins A1, E1 and Vimentin as Downstream Targets of Heme Oxygenase-1 in Vascular Endothelial Growth Factor-Mediated Angiogenesis","volume":"6","author":"Bauer","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"F1695","DOI":"10.1152\/ajprenal.00246.2018","article-title":"Periostin Overexpression in Collecting Ducts Accelerates Renal Cyst Growth and Fibrosis in Polycystic Kidney Disease","volume":"315","author":"Raman","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/TP.0000000000001729","article-title":"MTOR Inhibition and Kidney Diseases","volume":"102","author":"Ma","year":"2018","journal-title":"Transplantation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000354398","article-title":"Long-Term Treatment with Mammalian Target of Rapamycin Inhibitor Does Not Benefit Patients with Autosomal Dominant Polycystic Kidney Disease: A Meta-Analysis","volume":"124","author":"Xue","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000339440","article-title":"Early Arterial Stiffness and Inflammatory Bio-Markers in Normotensive Polycystic Kidney Disease Patients","volume":"36","author":"Kocyigit","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1159\/000489911","article-title":"Serum Fas Ligand, Serum Myostatin and Urine TGF-\u03921 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function","volume":"43","author":"Raptis","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12645","article-title":"Vasopressin: Physiology, Assessment and Osmosensation","volume":"282","author":"Bankir","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems Biology of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Computational Identification of Gene Expression Pathways and Integrated Regulatory Networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1590\/S0100-879X2011007500068","article-title":"Molecular and Cellular Pathogenesis of Autosomal Dominant Polycystic Kidney Disease","volume":"44","author":"Bastos","year":"2011","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies Targeting CAMP Signaling in the Treatment of Polycystic Kidney Disease","volume":"25","author":"Torres","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic Mechanisms and Signaling Pathways in Autosomal Dominant Polycystic Kidney Disease","volume":"124","author":"Harris","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The Hallmarks of Cancer: Relevance to the Pathogenesis of Polycystic Kidney Disease","volume":"11","author":"Geynisman","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5527\/wjn.v5.i1.76","article-title":"Role of Calcium in Polycystic Kidney Disease: From Signaling to Pathology","volume":"5","author":"Mangolini","year":"2016","journal-title":"World J. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1152\/physiolgenomics.00027.2016","article-title":"Heterotrimeric G Protein Signaling in Polycystic Kidney Disease","volume":"48","author":"Hama","year":"2016","journal-title":"Physiol. Genom."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Bader, G.D., and Hogue, C.W.V. (2003). An Automated Method for Finding Molecular Complexes in Large Protein Interaction Networks. BMC Bioinform., 4.","DOI":"10.1186\/1471-2105-4-2"},{"key":"ref_60","first-page":"29","article-title":"Predictive Biomarkers for Linking Disease Pathology and Drug Effect","volume":"23","author":"Mayer","year":"2017","journal-title":"Curr. Pharm. Des."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6885\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:24:55Z","timestamp":1760163895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":60,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22136885"],"URL":"https:\/\/doi.org\/10.3390\/ijms22136885","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]}}}